Correlation Between BioInvent International and ExpreS2ion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioInvent International and ExpreS2ion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and ExpreS2ion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioInvent International AB and ExpreS2ion Biotech Holding, you can compare the effects of market volatilities on BioInvent International and ExpreS2ion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of ExpreS2ion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and ExpreS2ion Biotech.

Diversification Opportunities for BioInvent International and ExpreS2ion Biotech

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BioInvent and ExpreS2ion is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and ExpreS2ion Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ExpreS2ion Biotech and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with ExpreS2ion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ExpreS2ion Biotech has no effect on the direction of BioInvent International i.e., BioInvent International and ExpreS2ion Biotech go up and down completely randomly.

Pair Corralation between BioInvent International and ExpreS2ion Biotech

Assuming the 90 days trading horizon BioInvent International is expected to generate 1.03 times less return on investment than ExpreS2ion Biotech. But when comparing it to its historical volatility, BioInvent International AB is 1.48 times less risky than ExpreS2ion Biotech. It trades about 0.13 of its potential returns per unit of risk. ExpreS2ion Biotech Holding is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  1,940  in ExpreS2ion Biotech Holding on April 21, 2025 and sell it today you would earn a total of  555.00  from holding ExpreS2ion Biotech Holding or generate 28.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BioInvent International AB  vs.  ExpreS2ion Biotech Holding

 Performance 
       Timeline  
BioInvent International 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point.
ExpreS2ion Biotech 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ExpreS2ion Biotech Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ExpreS2ion Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

BioInvent International and ExpreS2ion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioInvent International and ExpreS2ion Biotech

The main advantage of trading using opposite BioInvent International and ExpreS2ion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, ExpreS2ion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will offset losses from the drop in ExpreS2ion Biotech's long position.
The idea behind BioInvent International AB and ExpreS2ion Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets